| HBIa | FT-IR | XRDd | NMRe |
---|
 | A3400/A1323 | TCI (A1369/A2900)b | LOI (A1423/A899)c |  |  |
---|
Control | 3.46 | 0.48 | 0.99 | 40.53 | 34.83 |
F1-a | 3.79 | 0.54 | 2.01 | 42.62 | 37.90 |
F1-b | 4.78 | 0.59 | 1.05 | 46.42 | 40.81 |
F8-a | 3.84 | 0.55 | 1.83 | 44.82 | 39.41 |
F8-b | 4.84 | 0.60 | 1.54 | 46.47 | 41.26 |
Q1-a | 4.06 | 0.50 | 1.86 | 42.68 | 34.83 |
Q1-b | 4.65 | 0.61 | 1.82 | 45.56 | 37.90 |
Q4-a | 3.59 | 0.56 | 1.70 | 41.73 | 36.90 |
Q4-b | 4.10 | 0.60 | 1.67 | 48.64 | 38.99 |
- aHBI – hydrogen bond intensity which is the ratio of A3400 cm−1 and A1323 cm−1 from FT-IR spectra.
- bTCI – total crystallinity index which is the ratio of A1369 cm−1 and A2900 cm−1 from FT-IR spectra.
- cLOI – lateral order index was determined as the ratio of two absorption bands of A1423 cm–1 and A899 cm–1 from FT-IR spectra.
- dCrI was calculated based on the height of the peak corresponding to (002) lattice plane (I002) and the minimum between 110 and 002 lattice planes (Iam) as below: CrI (%) = (I002 – Iam) / I002.
- eCrI was calculated from the ratio of the crystalline area over the total area, where separation of crystalline (86 – 92 ppm) and amorphous (80 – 86 ppm).